Get the Stockscreener App
34.15
0.03%
-0.010
Sanara Medtech Inc stock is traded at $34.15, with a volume of 625.48K.
It is down -0.03% in the last 24 hours and up +45.63% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
See More
Previous Close:
$34.16
Open:
$34.105
24h Volume:
625.48K
Relative Volume:
3.75
Market Cap:
$313.94M
Revenue:
$103.14M
Net Income/Loss:
$-5.82M
P/E Ratio:
-7.8459
EPS:
-4.3526
Net Cash Flow:
$2.14M
1W Performance:
+0.15%
1M Performance:
+45.63%
6M Performance:
+80.59%
1Y Performance:
+12.34%
1-Day Range:
$34.09
$34.23
1-Week Range:
$33.68
$34.39
52-Week Range:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
34.15 | 315.60M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Lake Street | Buy |
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) furnishes Q2 2026 financial results press release - Stock Titan
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech (SMTI) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX - Sahm
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - marketscreener.com
How (SMTI) Movements Inform Risk Allocation Models - Stock Traders Daily
Sanara MedTech (NASDAQ:SMTI) Downgraded by Wall Street Zen to Buy - MarketBeat
SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36 - webull.com
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)? - webull.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
Sanara MedTech (SMTI) agrees to $350 million cash‑and‑stock acquisition by MiMedx - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK) - GlobeNewswire
MIMEDX To Acquire Sanara MedTech In $350 Million Transaction - Pulse 2.0
MiMedx Group: Sanara Deal Comes At A Poor Time - Seeking Alpha
Sanara MedTech agrees to be acquired by MiMedx - TipRanks
MIMEDX to acquire Sanara MedTech for $350 million By Investing.com - Investing.com Nigeria
Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger - TradingView
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech - TradingView
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx Group, Inc. entered into a definitive merger agreement to acquire Sanara MedTech Inc. for approximately $340 million. - marketscreener.com
Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI - TradingView
Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SMTI|Sanara Medtech Inc|Price:25.560|Chg%:+0.060 - TradingKey
Sanara MedTech Company Profile & Introduction - Moomoo
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):